Overview

A Long Term Safety Study to Test the Combination of Aliskiren/ Amlodipine / Hydrochlorothiazide in Participants With Essential Hypertension

Status:
Completed
Trial end date:
2009-10-05
Target enrollment:
Participant gender:
Summary
This study tested the safety of the combination of aliskiren/amlodipine/hydrochlorothiazide in participants with essential hypertension.
Phase:
Phase 3
Details
Lead Sponsor:
Novartis
Treatments:
Amlodipine
Hydrochlorothiazide